Clinical Development of Hemostatic Agent ClotFoam for Severe Hemorrhage
BIOMEDICA MANAGEMENT CORP. · Department of Health and Human Services
Phase II2012$1,977,696
DESCRIPTION (provided by applicant): ClotFoam(R) , is a novel adhesive sealant composition and second-generation hemostatic agent. This biological agent was designed to arrest moderate to severe blood loss arising from…